Publicaciones (219) Publicaciones en las que ha participado algún/a investigador/a

2024

  1. A new fluorescent probe for the visualization of progerin

    Bioorganic Chemistry, Vol. 142

  2. Evolution of human H3N2 influenza virus receptor specificity has substantially expanded the receptor-binding domain site

    Cell Host and Microbe, Vol. 32, Núm. 2, pp. 261-275.e4

2023

  1. A tumor-associated heparan sulfate-related glycosaminoglycan promotes the generation of functional regulatory T cells

    Cellular and Molecular Immunology, Vol. 20, Núm. 12, pp. 1499-1512

  2. C60-based Multivalent Glycoporphyrins Inhibit SARS-CoV-2 Specific Interaction with the DC-SIGN Transmembrane Receptor

    Small

  3. Cancer-Stem-Cell Phenotype-Guided Discovery of a Microbiota-Inspired Synthetic Compound Targeting NPM1 for Leukemia

    JACS Au

  4. Homogeneous immunoassay for cyclopiazonic acid based upon mimotopes and upconversion-resonance energy transfer

    Biosensors and Bioelectronics, Vol. 233

  5. New Pharmacological Approaches for Rare Diseases

    International Journal of Molecular Sciences

  6. N′-Phenylacetohydrazide Derivatives as Potent Ebola Virus Entry Inhibitors with an Improved Pharmacokinetic Profile

    Journal of Medicinal Chemistry, Vol. 66, Núm. 8, pp. 5465-5483

  7. Revealing the Specificity of Human H1 Influenza A Viruses to Complex N-Glycans

    JACS Au, Vol. 3, Núm. 3, pp. 868-878

  8. Selective inhibition of cannabinoid CB1 receptor-evoked signalling by the interacting protein GAP43

    Neuropharmacology, Vol. 240

2022

  1. 2-(Fluoromethoxy)-4′-(S-methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D1Receptor for Parkinson's Disease

    Journal of Medicinal Chemistry, Vol. 65, Núm. 18, pp. 12256-12272

  2. Biosensing Tacrolimus in Human Whole Blood by Using a Drug Receptor Fused to the Emerald Green Fluorescent Protein

    Analytical Chemistry, Vol. 94, Núm. 47, pp. 16337-16344

  3. Cannabinoid WIN55212-2 impairs peanut-allergic sensitization and promotes the generation of allergen-specific regulatory T cells

    Clinical and Experimental Allergy, Vol. 52, Núm. 4, pp. 540-549

  4. Cannabinoids induce functional Tregs by promoting tolerogenic DCs via autophagy and metabolic reprograming

    Mucosal Immunology, Vol. 15, Núm. 1, pp. 96-108

  5. Conformational and Structural Characterization of Carbohydrates and their Interactions Studied by NMR

    Current medicinal chemistry, Vol. 29, Núm. 7, pp. 1147-1172

  6. Discovery of V-0219: A Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor toward Oral Treatment for "diabesity"

    Journal of Medicinal Chemistry, Vol. 65, Núm. 7, pp. 5449-5461

  7. New Trends in Aging Drug Discovery

    Biomedicines, Vol. 10, Núm. 8

  8. Novel Antagonist of the Type 2 Lysophosphatidic Acid Receptor (LPA2), UCM-14216, Ameliorates Spinal Cord Injury in Mice

    Journal of Medicinal Chemistry, Vol. 65, Núm. 16, pp. 10956-10974

  9. The Search for Antibacterial Inhibitors Targeting Cell Division Protein FtsZ at Its Nucleotide and Allosteric Binding Sites

    Biomedicines, Vol. 10, Núm. 8

  10. The cannabinoid WIN55212-2 suppresses effector T-cell responses and promotes regulatory T cells in human tonsils

    Allergy: European Journal of Allergy and Clinical Immunology